Clinical trial · Interventional
Establishment and Clinical Application of Precise SLNB System in Breast Cancer: a Randomized, Multicenter, Controlled Study
Clinical Study on Regularity of Lymphatic Drainage and Surgical Treatment of Breast Cancer
NCT03857932CI-TRIAL-00053604unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigatorsconduct the precise sentinel lymph node biopsy using preoperative computed tomographic lymphography in breast cancer. The investigators aimed to summarize the law of lymphatic drainage of breast, and to conduct the accurate surgical treatment of breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Participants receive SLNB as well as non SLNs resection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- SLNB and non-slns resection
- description
- 1. Participants only receive SLNB 2. preoperative CT lymphography 3. SLNB with stained non-SLN resection 4. SLNB with ARM dissection
- interventionNames
- Procedure: Participants receive SLNB as well as non SLNs resection
- type
- EXPERIMENTAL
- label
- SLNB group
- description
- Participants only receive SLNB
- interventionNames
- Procedure: Participants receive SLNB as well as non SLNs resection
Primary outcomes (1)
- measure
- Disease free survival
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. histologically confirmed primary breast cancer by core needle biopsy or excisional biopsy 2. abnormal para-sentinel lymph node was found by ultrasound examination 3. ultrasound-guided fine needle aspiration cytology of these nodes were performed 4. the result of fine needle aspiration cytology was negative (no tumour cell was found) 5. participants planed to perform SLNB Exclusion Criteria: 1. pathological diagnosed ductal carcinoma in situ by excisional biopsy 2. the result of fine needle aspiration cytology was positive 3. participants has received neo-adjuvant system therapy
References
Publications (0)
Data not yet available
No reference posted for this study.